sentence: 17-estradiol, a master hormone in reproductive processes, regulates leptin expression in trophoblastic BeWo cells and placental explants through nongenomic actions involving membrane associated ERalpha.
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The blastocyst development and implantation is governed by an extremely complicated but cooperative interplay of various cellular factors and biomolecules, which are regulated in a defined spatio temporal fashion. One of the important aspects of blastocyst implantation is the involvement of regulatory molecules, primarily embryotrophic factors, which encompass second messengers, transcription factors, proteases, growth factors and cytokines [8] .
In particular, leptin has been proposed to play a relevant role in implantation and in placenta growth and survival during pregnancy [9] [10] [11] . Leptin hormone, the product of the LEP gene, is a 16000 MW non-glycosylated polypeptide of 146 amino acids discovered in 1994 by Zhang et al [12] .
In humans, the placenta is a significant source of maternal circulating leptin, with levels in the second and third trimesters being up to 200% of those in the first trimester or in the non-gravid situation [13] . Many physiological roles have been suggested for leptin in human pregnancy. Both leptin and leptin receptors have been identified in the placental syncytiotrophoblast, which suggests the potential for autocrine and paracrine mechanisms. Leptin also activated the release of proinflammatory cytokines and prostaglandins from human placental explants, further implicating leptin as a modulator of placental endocrine function. On the other hand, deregulation of leptin metabolism and/or leptin function in the placenta may be implicated in the pathogenesis of various disorders during pregnancy, such as recurrent miscarriage, gestational diabetes, intrauterine growth retardation, and preeclampsia [14, 15] .
The complete regulation of leptin production in the placenta is still poorly understood. Previous work demonstrated that hCG and cAMP enhances leptin expression through a crosstalk between PKA and MAPK signaling pathways [16, 17] .
Human placenta is known to synthesize estrogens during pregnancy [18] , in association with the cytotrophoblast invasion [19, 20] . Moreover, there is evidence to suggest that placentally derived estrogen may play an autocrine role in trophoblast differentiation [21, 22] .
Estrogens have been reported to regulate leptin expression by acting on a portion of the estrogen response element in the leptin promoter [23] . The presence of estrogen receptor in primate A C C E P T E D M A N U S C R I P T
trophoblast [22] suggests that, this is an estrogen receptor-mediated phenomenon. Estrogen receptor ER  and  proteins have also been localized in nuclei of cultured human syncytiotrophoblast cells using immunohistochemistry [22] .
Although these findings suggest the importance of estrogens in leptin biosynthesis, the mechanisms that mediate leptin expression by estrogen in human placenta remain undefined. In our previous work [24, 25] , we showed that E 2 indeed upregulates leptin expression in human placental cells probably involving genomic and nongenomic action by a crosstalk between ERand the MAPK and PI3K signal transduction pathways. To improve the understanding of estrogen receptor mechanisms in regulating placental leptin expression, we here examined the effect of membraneconstrained E 2 conjugate, E-BSA, on leptin expression in human placental cells. Our present results
suggest that E 2 , a key regulator of leptin expression in placenta, involves ER membrane associated via nonclassical estrogen receptor pathway.
Materials and methods
Cell culture and treatments
The human choriocarcinoma cell line BeWo was grown in 45% Dulbecco Modified Eagle Medium (DMEM) and 45% HAM F-12 (Invitrogen, Carlsbad, CA) supplemented with 10% fetal calf serum (FCS), 100 U/ml penicillin, 100 g/ml streptomycin, 2 mM glutamine (Invitrogen), and 1 mM sodium pyruvate (Sigma Chemical Company, St. Louis, MO) at 37ºC in 5% CO 2 .
The effect of 17-estradiol (E 2 ; Sigma) was previously tested at different doses and 10 or 100 nM E 2 was used in subsequent experiments [24] . The antiestrogen ICI 182,780 (AstraZeneca, UK, London) was used to assay the specificity of estrogen effects. Membrane estrogen actions were evidenced incubating with estradiol covalently linked to BSA (E-BSA, -Estradiol 6-(Ocarboxymethyl)oxime:BSA; Sigma). E-BSA was filtered prior to use in order to eliminate free E 2 according with a previously described method [26] . Briefly, 900 l of E-BSA (400 M in estradiol
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dissolved in 50 mM Tris-HCl pH 8.5) was added to a centrifugal filter unit with a MW cut-off of 3,000 (Millipore, Billerica, MA) and subjected to centrifugation at 13,000 × g for 30 min. The retained fraction was washed 3 times with buffer and recovered. Volume was adjusted to 900 l.
The efficacy of filtration to remove free E 2 was verified by Stevis et al. [26] .
The specific PI3K inhibitors Wortmannin (0.1 M) and LY-294,002 (1 M), the MEK inhibitor PD98059 (50 µM), the p38-MAPK inhibitor SB 203580 (5 M) and the JNK inhibitor SP600125 (5 M) (Sigma) were also used. Treatments were performed in DMEM-F12 media without phenol red and supplemented with 1% charcoal stripped FCS unless otherwise stated. Serum present in incubation media was reduced from 10% to 1% to lower non-specific effects.
Placental explants collection and processing
Human placentas (n = 15) were obtained after cesarean section or vaginal delivery following normal term pregnancies and immediately suspended in ice-cold phosphate-buffered saline (PBS) and
transported to the laboratory, where they were washed 2-3 times in sterile PBS to remove excess blood. Villous tissue free of visible infarct, calcification, or hematoma was sampled from at least five cotyledons at a distance midway between the chorionic and basal plates. These core parts of cotyledons were cut into multiple cubic segments (10-15 mg wet weight) and thoroughly rinsed with cold DMEM-F12 medium. None of the donor patients suffered from anomalous pregnancy.
Samples were obtained under informed consent, and the study was approved by the Hospital Universitario Virgen Macarena (Seville, Spain) ethics committee.
Treatments of placental explants
Placental explants were randomly distributed in tubes containing 1 ml of DMEM-F12 medium without FCS (n = 1 explant/tube, 3 replicates per treatment). Placental explants were maintained in a shaking water bath at 37°C during 5 min to equilibrate temperature and incubated in the same For real-time PCR, after thoroughly washing with PBS, the explants were immediately frozen at -80 ºC and stored until extraction of total RNA.
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Membrane isolation
Membrane fractions were isolated by sucrose centrifugation according with a previously described method [27] . Briefly, BeWo cells were grown on 100 mm dishes in DMEM-F12 plus 1% FCS for 48 h, were washed with icecold PBS and scraped into 0.75 mL sucrose buffer (50 mM Tris, 1 nM EDTA, 200 mM sucrose, 4 mM NaHPO 4 , 1 M Na 3 VO 4 , 1 M NaF). Cells were homogenized by passing the sample forty times through a syringe needle. Homogenates were spun at 1000 × g at 4 ºC. The pellet was resuspended in solubilization buffer (10 mM Tris-HCl pH 7.4, 1 mM EDTA, 0.5% Triton X-100 plus protease and phosphatase inhibitors) and labeled "nuclear." Supernatant was spun at 20000 × g for 75 min at 4 °C. The pellet was resuspended in solubilization buffer and labeled "membrane" and supernatant was labeled "cytoplasm." All the fractions were analyzed by Western blot.
Western blot analysis
Total cell lysates were prepared in lysis buffer. The lysates were centrifuged at 10000 × g for 10 min to remove cellular debris. The protein concentration of the supernatant was determined by Loading controls were performed by immunoblotting the same membranes with polyclonal rabbit anti-actin (1:1000; Sigma), with monoclonal mouse anti-tubulin (1:1000; Sigma), with polyclonal rabbit anti-total-MAPK kinase 1 and 2 (MEK 1/2; 1:3000; Sigma), with polyclonal rabbit anti-total-MAPK 1 and 2 (ERK 1/2; 1:3000; Sigma) or with polyclonal rabbit anti-total-AKT antibody (1:3000; Sigma).
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Bound antibodies were detected using horseradish peroxidase-linked donkey anti-rabbit IgG 
Plasmids
The luciferase (Luc) reporter construct pL1951 is based on pGL-3 basic vector. They were kindly To perform transient transfection assays, plasmids were purified using the Maxipreps Wizard kit (Promega Co., Madison, WI), and the concentration of DNA was estimated spectrophotometrically.
Transient transfection experiments
For transient transfection experiments, BeWo cells were plated at a density of 2.5 x 10 5 cells/ml onto six-well dishes containing 2 ml of DMEM-F12 plus 10% FCS. Cells were incubated for 24 h.
Medium was replaced and transfection of cells was performed according to the standard liposomemediated method.
When reporter plasmids were used, the sensitivity of the method was determined in this cell type, performing a standard dose of reporter plasmid vs. light emission (data not shown). Typically 5 g Transfection of cells with Sh2 plasmid was performed according to the method previously described, using 5 g of Sh2/well. Two days after transfection, the medium was replaced with DMEM-F12 10% containing 500 g/ml G418 (Sigma). A standard dose-response curve was performed to evaluate cell sensitivity to G418 (data not shown).
Cell derived clones were serially expanded and passed at least 10 times in G418 containing medium before using for analysis. Expression of ERshRNA was induced incubating cells with DMEM-F12 1% charcoal stripped FCS containing 5 g/ml doxycycline (Pfizer, New York, NY) during 48 h.
Assays for Luc and -galactosidase activities
Luc activity in cell lysates was measured using the Luciferase Assay System (Promega). Cells were washed with PBS and harvested 48 h after the transfection procedure using 50 l of lysis buffer. 
Immunofluorescence
BeWo cells were grown on coverslips overnight in DMEM-F12 plus 10% FCS. Then were washed three times in PBS and fixed 5 min at RT with 2.0% paraformaldehyde, 0.5% Nonidet P-40 (NP-40)
and 0.15 M sucrose in PBS pH 7.4; freshly prepared, according a previous described method [32] .
At the end of the fixation period, the cells were washed three times with PBS, and blocked where control values were taken as 1. Statistical analysis was performed using the Graph Pad Prism computer program (GraphPad Software, San Diego, CA). Statistical significance was assessed by ANOVA followed by different post hoc tests, as indicated in each figure. A p-value < 0.05 was considered statistically significant.
Results
Estradiol-BSA enhances endogenous leptin expression in placental cells
We have previously observed that E 2 was able to induce leptin expression not only in BeWo cells but also in human placental explants. Our results strongly suggest that E 2 action probably involves both genomic and nongenomic actions [24] . In order to evidence the involvement of membrane receptors in E 2 signaling, we aimed to study the effect of membrane-constrained E 2 conjugate, E-BSA, on leptin expression in human placental cells.
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As seen in Figure 1A , E-BSA enhanced leptin expression in BeWo cells as determined by Western blot analysis. This effect was dose dependent, reaching a 2.2-fold maximal increase at 100 nM. We next performed transient transfection assays with a vector containing the regulatory region of leptin gene from -1951 bp fused to the Luc reporter gene (pL1951). As shown in Figure 1B , in transfected
BeWo cells, treatment with 10 nM E-BSA for 48h induced a 5.6-fold maximal increase in Luc activity. A control treatment with 100 nM E 2 was included; it significantly enhanced leptin expression as previously reported [24] . In order to analyze whether E-BSA stimulates leptin at the transcriptional level in a more physiological model, additional experiments were performed in placental explants. Figure 1C shows that E-BSA significantly enhanced leptin mRNA expression, measured by qRT-PCR in human placental explants. Maximal effect was achieved at 10 nM with a 3.9-fold increase. Control treatment with 0.1 nM E 2 significantly enhanced leptin expression.
To confirm that E-BSA is not a membrane-permeable compound, BeWo cells were transfected with a luciferase reporter construct driven by a minimal promoter containing tandem repeats of a canonical ERE, and then stimulated with E 2 or E-BSA as indicated for 48 h ( Figure 1D ). Compared with control, E 2 triggered over a 3.7-fold increase in ERE-driven Luc activity, whereas E-BSA had no effect.
Taken together, these results suggest that E-BSA increases placental leptin expression through estrogen membrane-initiated actions.
Estradiol-BSA activates multiple signal transduction pathways
Estrogen action mediated by membrane receptors are frequently associated with the activation of many protein-kinase cascades [33] . So, our next aim was to investigate whether E-BSA could activate different signaling transduction pathways in placental cells.
As shown in Figure 2 , ERK1/2, AKT, p38-MAPK and JNK phosphorylation were increased with E-BSA treatment in n BeWo cells, and these effects were dose dependent. On the other hand, E-
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BSA increased MEK, ERK1/2 and AKT phosphorylation in placental explants, but did not affect p38-MAPK and JNK phosphorylation (Figure 3 ).
These results suggest that E-BSA is able to activate MAPKs and PI3K signal transduction pathways in placental cells.
Estradiol-BSA involves multiple signaling pathways in the induction of leptin expression
Recent evidence suggest that estrogen membrane initiated actions may indirectly influence gene expression, through the activation of signal transduction pathways that eventually act on target transcription factors [2] . E-BSA enhanced leptin expression and also activated different signaling pathways in placental cells, therefore we decided to analyze if those signaling pathways are involved in E-BSA induction of leptin expression.
Results obtained in transfected BeWo cells ( Figure 4A ), showed that leptin promoter activity Similar experiments were performed in human placental explants, a more physiological model. In these experiments explants were pretreated with the same pharmacological inhibitors and then incubated with 10 nM E-BSA for 4 h. Treatments with all the inhibitors tested significantly blocked the effect of E-BSA on leptin expression measured by qRT-PCR ( Figure 4B ), suggesting that
MAPKs and PI3K pathways are involved in E-BSA leptin induction.
ER is localized both in nucleus and plasma membranes of BeWo cells
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Estrogen receptors have been localized to the plasma membrane where both ER and ER function in a wide variety of cells and organs [7] . The physiologic role of these plasma membrane binding sites for estrogens is currently under intense investigation. We decided to investigate if ER andER estrogen receptors are present in plasma membrane of BeWo cells by two different experimental approaches: Western blot of subcellular fractions and immunofluorescence.
In total sample the 66 KDa band corresponding to ERwas observed. Analyzing subcellular fractions obtained by sucrose gradients of BeWo cells, we detected ER in nuclear and also in membrane fractions ( Figure 5A ). Three detectable bands were observed between 66 and 50 KDa, probably due to partial degradation or to fractionation artifacts.
By the other side, ER appears to be mainly nuclear, although it has been slightly detected in cytosol of BeWo cells ( Figure 5A ).
In order to evidence whether the treatment with E 2 or E-BSA alters the distribution of ER, similar cellular fractionation experiments were performed in the presence of the hormone. As it can be seen in Figure 5B HDAC1 and G-protein subunit detection were used as control of quality of nucleus and membrane fractions respectively. As it can be seen in Figures 5A and 5B both proteins were only revealed in their specific compartments.
By a different experimental approach as immunofluorescence, similar results were obtained. ER was detected mainly in nucleus and in plasma membrane of BeWo cells ( Figure 6A ) meanwhile ER is predominantly nuclear ( Figure 6B ). Immunofluorescence results were confirmed by confocal microscopy (Figure 6D and 6E) .
Negative controls in the absence of primary antibodies were also performed ( Figure 6C and 6F) .
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These results strongly suggest that ER is localized both in nucleus and plasma membrane of trophoblastic cells, and could be involved in estrogen regulation of placental leptin expression.
Estradiol action probably involves ER membrane receptors
Finally, we analyzed if ER membrane receptor could mediate membrane-initiated estrogen actions involved in placental leptin expression.
The antiestrogen ICI 182,780 was used to assay if E-BSA effects depends on the presence of functional estrogen receptors. When placental explants were pretreated with 100 nM ICI 182,780, the stimulatory effect of E-BSA on leptin expression was prevented ( Figure 7A ). Moreover, in the presence of 100 nM ICI 182,780, E-BSA failed to induce ERK 1/2 phosphorylation ( Figure 7B ). By the other side 100 nM ICI 182,780 increased AKT phosphorylation, probably due to some agonist effect of this antiestrogen ( Figure 7C ). These results suggest that ICI 182,780 can block some of the effects of E-BSA in placental explants.
In a different experimental approach siRNA silencing against ERwas carried out. BeWo cells were stable transfected with Sh2 construct to decrease ERprotein. Expression of ERsiRNA was induced incubating cells with 5 g/ml doxycycline, which showed no effect on ER or ER expression in non-transfected BeWo cells ( Figure 8A ).
In Figure 8B it is shown that ERsiRNA expression produced a marked reduction in the amount of ER protein in BeWo cells measured by Western blot. The ERsilencing was specific, as ER level was not modified in Sh2 transfected cells treated with doxycycline. In Sh2 transfected cells, not induced with doxycycline, the incubation with 100 nM estradiol or 1-100 nM E-BSA increased leptin promoter activity ( Figure 8D ). Besides, ERproteinwas not totally downregulated when
ERsiRNA expression was induced with doxycycline. In this scenario the treatment with E 2 or E-BSA failed to induce leptin expression ( Figure 8C ) and leptin promoter activity ( Figure 8D ). On the other hand, it was previously demonstrated that E-BSA treatment probably does not exert its effect
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on leptin expression through an intracellular ER ( Figure 1D ). All together these results strongly suggest that in BeWo cells, the membrane receptor/s involved in E-BSA induced leptin expression could be membrane associated ER 
Discussion
The steroid hormone 17-estradiol (E 2 ) is an estrogen that regulates growth, differentiation, and function in a wide array of target tissues, including the male and female reproductive tracts, mammary gland, and skeletal and cardiovascular systems [34] . It exerts some effects through the action of classical estrogen receptors ER and ER which act as ligand-activated transcription factors and regulate gene expression [33] . In addition, E 2 can elicit rapid responses from membraneassociated receptors, like activation of protein kinase pathways, which can result in the modification of transcriptional activity of conventional transcription factors. Thus the cellular effects of E 2 will depend on the specific receptors expressed and the integration of their stimulatory and inhibitory signaling events [35] .
During human pregnancy, the production of E 2 raises eighty fold, from 0.75 nM preovulatory peak to 60 nM at term. Estradiol influences various aspects of placental function and fetal development in humans and primates [36] , and plays a role in the regulation of fetal growth, onset of parturition, placental steroideogenesis, release of neuropeptides, release of glycoproteins and leptin secretion [37] . Leptin is a key hormone in trophoblast proliferation and survival [25] , that regulates cell proliferation by inhibiting apoptosis [10, 11] , stimulates protein synthesis [38] , and regulates fetal growth and development [39] .
The regulation and physiology of leptin in placenta is largely unknown, and in particular little is known about the mechanisms involved in regulation of leptin expression by E 2 in placental cells. It was previously reported that E 2 increased leptin production in cultured human cytotrophoblastic cells from first trimester placenta [37] . Moreover, it was demonstrated that E 2 enhanced leptin
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promoter activity in JEG-3 cells, suggesting that E 2 regulates LEP gene expression via promoter activation [23] . Those investigations suggest that E 2 could be an important regulator of leptin expression in placental cells. Our previous results indicated that E 2 induces leptin expression not only in BeWo cells but also in human placental explants probably involving both soluble and membrane estrogen receptors [24] .
In this regard, we aimed to study the regulation of leptin expression by E-BSA, an estrogen analogue that evidence membrane-iniciated estrogen actions [40] . We used two experimental models: BeWo choriocarcinoma cells and human placental explants. BeWo cells maintain many characteristics of human trophoblast cells and have been widely used to study placental cellular signaling [41] [42] [43] . Normal placental explants from healthy donors were also studied to confirm the physiological relevance of the results.
When the effect of E-BSA on leptin expression was analyzed in BeWo cells and human placental explants, a significant upregulation was observed. Moreover, we observed that E-BSA was able to increase leptin promoter activity and leptin mRNA transcription. These genomics effects could not be attributed to classic nuclear ERs, as E-BSA, in contrast to E 2 , failed to stimulate the reporter activity of ERE-Luc plasmid. These results confirmed the membrane-constraint property of E-BSA and suggested that its actions are probably triggered by plasma membrane receptors.
We observed that high concentration of E-BSA was less efficient on leptin expression induction than low concentration in both experimental models. Similar results were obtained with E 2 effect on leptin expression in placental cells [24] , and are also in agreement with the bifasic modulation of human cytotrophoblastic leptin secretion by E 2 [37] . The underlying molecular mechanism is not completely understood. It has been proposed that high doses of E 2 or E-BSA could downregulate the expression of estrogen receptors, as observed in other reproductive tissues, but this hypothesis remains to be studied in placental cells. Our results are in agreement with previous reports, where it has been shown that E 2 can exert rapid non-genomic effects in human placental explants, inducing ERK 1/2 and AKT phosphorylation.
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The blockage of these pathways in BeWo cells prevented the effect of E 2 on leptin expression both at protein and transcriptional levels [24] .
Various regulatory elements have been identified within the leptin promoter, e.g., cAMP, estrogen, androgen, insulin and glucocorticoid response elements, CCATT/enhancer and SP1 binding sites, suggesting a direct regulation of leptin expression through different transcriptional pathways [25] .
Several transcription factors that recognize those regulatory elements could be interacting with nuclear estrogen receptors or could be modulated by protein kinases activated by membraneiniciated estrogen actions, as it has been widely reported [2] . Further experiments will be needed to understand the possible mechanisms of integration of membrane signaling and nuclear effects of E 2 involved in human placental leptin expression.
It is known that E 2 exerts its actions through two members of the nuclear receptor superfamily, estrogen receptor ERand ER, and also through a G protein coupled membrane receptor, GPR30 [45] . The presence of estrogen receptor in primate trophoblast suggests that, as in adipose tissue, the effect of estrogen on leptin expression is an estrogen receptor-mediated phenomenon [46] .
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Although term placenta has been found to specifically bind estrogens, cellular localization of ER in trophoblasts remains unclear [36] . Immunohistochemistry in term placenta sections showed that the ERα was strongly expressed in cytotrophoblast nuclei, lying beneath trophoblastic syncytium, which showed no staining of the nuclei. ERα immunoreactivity was also detected in villous vessels and sinusoids [36] . By the other side, reverse transcription-polymerase chain reaction and Western analyses showed the presence of ER transcripts and protein in BeWo cells. The BeWo cell ER binds to an ERE consensus sequence, suggesting that these cells express a functional ER [47] .
It has also been reported that human term placental tissues express ER and it was localized in the syncytiotrophoblast layer and in only few cells of the cytotrophoblast; no staining was observed in the stromal region. The presence of ER mRNA was also detected in BeWo choriocarcinoma cell line, and its expression -but not the ER expression-is down-regulated by E 2 [48] . Our results suggest that BeWo cells express ER and it appears to be mainly nuclear, although cytosolic ER was also detected by immunofluorescence.
Previous results support the involvement of ER in placental leptin expression, as the overexpression of ER in BeWo cells increased the stimulatory effect of E 2 on leptin promoter activity [24] . Moreover, it has been proposed that the expression of ER and not of ERevidenced the stimulatory effect of E 2 on leptin expression in JEG-3 cells [23] .
In the present work we showed that BeWo cells express ER mainly detected in nucleus and plasma membrane, but also cytosolic protein was detected by immunofluorescence.
These results are consistent with previous reports of Bukovsky et al. [36] . They observed that trophoblast cultures derived from normal placenta exhibited surface ERα expression. Nondividing trophoblast cells showed cytoplasmic/perinuclear or perinuclear/nuclear ERα immunoreactivity, which was accompanied by diminution of cell surface staining [36] .
The blockage of E-BSA effects on ERK phosphorylation and leptin mRNA expression with the antiestrogen ICI 182,780 that ER could be the receptor involved in membrane-initiated estrogen Our results suggest that leptin physiology may also depend of membrane-associated estrogen effects.
In the late 1990s was revealed the existence of the receptor GPR30, a member of the G protein- Further experiments will be needed to analyze if GPR30 is expressed in trophoblastic cells and participates in E 2 up-regulation of placental leptin expression.
Conclusions
In summary, in this study, we provide evidence that E-BSA induces leptin expression through the activation of multiple signaling pathways that could regulate leptin gene expression. The possible mechanism of regulation of placental leptin expression by E 2 is a multifactorial process, and may depend on the presence, concentration and localization of ERs, transcription factors, co-regulatory proteins and signal transducers, among others, as illustrated in the model based in current data shown in Figure 9 . Our results provide new evidence of the regulatory mechanisms of placental leptin expression and support the importance of leptin in reproduction. 
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Immunolocalization of ERs in BeWo cells
A-F, BeWo cells were fixed, permeabilized and blocked as described in Materials and Methods.
Cells were incubated ON with anti ER (A and D), anti ER (B and E) or with no primary antibody as negative control (C and F). A Cy3-labeled anti-rabbit was used to detect bounded primary antibodies. Cells were stained with Hoechst 33342, mounted with Mowiol 4-88, and examined in a conventional fluorescence microscope (A-C) or in a confocal fluorescence microscope (D-F).
Representative images of four independent experiments are shown. Bar size: 50m. Neg: Negative control.
Figure 7
The antiestrogen ICI 182,780 antagonized E-BSA effects A, Placental explants were processed as previously described, pretreated during 20 min with 100 nM ICI 182,780 and then further incubated with E-BSA as indicated during 4 h. Total RNA was extracted as described in Materials and Methods. Leptin mRNA was quantified with real-time RT-PCR. Cyclophilin was used as internal standard.
B-C, Placental explants were processed as previously described, pretreated during 20 min with 100 nM ICI 182,780 and then further incubated with E-BSA as indicated for 10 min. ERK 1/2 (B) or AKT (C) phosphorylation were determined by Western blot as indicated in Materials and Methods.
Total ERK 1/2 or AKT protein levels in cell extracts were determined.
Results are expressed as mean  SEM for three independent experiments performed in triplicates. 
